Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | AMG 596 |
Synonyms | |
Therapy Description |
AMG 596 is a bispecific antibody that targets CD3 on T-cells and the Egfr variant, EGFRvIII, expressed by tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
AMG 596 | AMG596|AMG-596 | EGFR Antibody 60 | AMG 596 is a bispecific antibody that targets CD3 on T-cells and the Egfr variant, EGFRvIII, expressed by tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03296696 | Phase I | AMG 596 | Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma | Terminated | USA | NLD | FRA | ESP | DEU | AUS | 0 |